
84.49 Delayed Data As of Dec 01 | ![]() Today’s Change | 55.25 Today|||52-Week Range 159.89 | -34.80% Year-to-Date |
Sarepta Therapeutics (SRPT) Up 4.5% Since Last Earnings Report: Can It Continue? Dec 01 / Zacks.com - Paid Partner Content | Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug Nov 23 / Zacks.com - Paid Partner Content |
Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 82.64%: Read This Before Placing a Bet Nov 29 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights Gilead Sciences, Legend Biotech, BeiGene, Exact Sciences and Sarepta Therapeutics Nov 21 / Zacks.com - Paid Partner Content |
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Nov 27 / Zacks.com - Paid Partner Content | 5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024 Nov 20 / Zacks.com - Paid Partner Content |
Previous close | 81.28 |
Today’s open | 81.26 |
Day’s range | 78.69 - 84.49 |
Volume | 61,892 |
Average volume (3 months) | 1,361,849 |
Market cap | $7.7B |
Earnings growth (last year) | -55.90% |
Earnings growth (this year) | -26.56% |
Earnings growth (next 5 years) | +67.30% |
Revenue growth (last year) | +32.93% |
P/E ratio | NM |
Price/Sales | 12.16 |
Price/Book | 18.92 |
Today’s change | Today’s % change | |
---|---|---|
JAZZJazz Pharmaceuticals... | +0.97 | +0.82% |
KRTXKaruna Therapeutics ... | +5.27 | +2.76% |
IONSIonis Pharmaceutical... | +2.16 | +4.37% |
APLSApellis Pharmaceutic... | +7.65 | +14.20% |
Next reporting date | February 27, 2024 |
EPS forecast (this quarter) | -$1.24 |
Annual revenue (last year) | $933.0M |
Annual profit (last year) | -$703.5M |
Net profit margin | -75.40% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |